132 related articles for article (PubMed ID: 1704988)
1. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
Limas CJ; Limas C
J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
4. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase.
Arnold IR; Mistry R; Barnett DB
J Cardiovasc Pharmacol; 1993 Sep; 22(3):481-7. PubMed ID: 7504142
[TBL] [Abstract][Full Text] [Related]
6. Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase.
Arnold IR; Mistry R; Barnett DB
Eur J Pharmacol; 1993 May; 245(3):285-9. PubMed ID: 8392940
[TBL] [Abstract][Full Text] [Related]
7. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
Barnett DB; Lu XY
Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
[TBL] [Abstract][Full Text] [Related]
8. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.
Lemoine H; Bilski A; Kaumann AJ
J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921
[TBL] [Abstract][Full Text] [Related]
9. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
10. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
11. Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes.
Reithmann C; Panzner B; Werdan K
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):530-40. PubMed ID: 1356232
[TBL] [Abstract][Full Text] [Related]
12. Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes.
Paraschos A; Karliner JS
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):267-76. PubMed ID: 7824043
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
Persad S; Takeda S; Panagia V; Dhalla NS
J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors.
Reithmann C; Wieland F; Jakobs KH; Werdan K
Eur J Pharmacol; 1989 Nov; 170(3):243-55. PubMed ID: 2575997
[TBL] [Abstract][Full Text] [Related]
17. Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats.
Fujii K; Onaka U; Goto K; Abe I; Fujishima M
Hypertension; 1999 Aug; 34(2):222-8. PubMed ID: 10454445
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
19. Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways.
Karle CA; Zitron E; Zhang W; Kathöfer S; Schoels W; Kiehn J
Cardiovasc Res; 2002 Feb; 53(2):355-62. PubMed ID: 11827686
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
